Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practice

Y Lin, Y Shao, J Yan, G Ye - Journal of Clinical Laboratory …, 2023 - Wiley Online Library
Increasing rates of Helicobacter pylori resistance are associated with multiple clinical
challenges. Bacterial factors linked to H. pylori resistance are mutations, efflux pumps, and …

Helicobacter pylori infection

P Malfertheiner, MC Camargo, E El-Omar… - Nature reviews Disease …, 2023 - nature.com
Helicobacter pylori infection causes chronic gastritis, which can progress to severe
gastroduodenal pathologies, including peptic ulcer, gastric cancer and gastric mucosa …

Carbonic Anhydrases: New Perspectives on Protein Functional Role and Inhibition in Helicobacter pylori

C Campestre, V De Luca, S Carradori… - Frontiers in …, 2021 - frontiersin.org
Our understanding of the function of bacterial carbonic anhydrases (CAs, EC 4.2. 1.1) has
increased significantly in the last years. CAs are metalloenzymes able to modulate CO2 …

[HTML][HTML] Clinical recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on diagnosis and treatment of gastritis and duodenitis

VT Ivashkin, IV Maev, TL Lapina, ED Fedorov… - Russian Journal of …, 2021 - gastro-j.ru
Aim. The clinical guidelines are intended to supplement specialty decision-making for
improved aid quality in patients with gastritis and duodenitis though acknowledging the …

The status and progress of first-line treatment against Helicobacter pylori infection: a review

C Liu, Y Wang, J Shi, C Zhang, J Nie… - Therapeutic …, 2021 - journals.sagepub.com
Helicobacter pylori (HP) is a major causative agent of chronic gastritis and peptic ulcer. HP
is also engaged in the development of gastric cancer and gastric mucosa-associated …

Best Helicobacter pylori Eradication Strategy in the Era of Antibiotic Resistance

SY Kim, JW Chung - Antibiotics, 2020 - mdpi.com
Antibiotic resistance is the major reason for Helicobacter pylori treatment failure, and the
increasing frequency of antibiotic resistance is a challenge for clinicians. Resistance to …

The cure rate of 10-day bismuth-containing quadruple therapy for Helicobacter pylori eradication is equivalent to 14-day: a systematic review and meta-analysis

YM Ding, YY Li, J Liu, J Wang, M Wan, MJ Lin… - Clinical and …, 2023 - Springer
Helicobacter pylori (H. pylori) infection is a major cause of duodenal ulcers, gastric ulcers,
and gastric cancer. However, the optimal duration for H. pylori eradication therapy remains …

Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of Helicobacter pylori infection: a systematic review and meta-analysis

G Yao, X Fan, D Lu - Journal of International Medical …, 2023 - journals.sagepub.com
Objective We performed a meta-analysis to determine whether the addition of probiotics to
the bismuth quadruple therapy (BQT) for Helicobacter pylori would improve the incidence of …

Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial

JH Cho, SY Jin, S Park - Expert Review of Anti-infective Therapy, 2022 - Taylor & Francis
Objectives We aimed to compare the success rate, adverse drug events, and cost-
effectiveness of tailored Helicobacter pylori eradication and modified bismuth-containing …

Клинические рекомендации Российской гастроэнтерологической ассоциации и ассоциации «Эндоскопическое общество РЭНДО» по диагностике и лечению …

ВТ Ивашкин, ИВ Маев, ТЛ Лапина, ЕД Федоров… - Scopus, 2021 - elib.usma.ru
Цель представления клинических рекомендаций заключается в обеспечении
информационной поддержки принятия врачами решений, способствующих повышению …